SCHEMBL30032159

SCHEMBL30032159

COC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 1/20 0.64
▸ NOS2 P35228 3/20 0.61
▸ NOS3 P29474 2/20 0.61
▸ NOS1 P29475 2/20 0.61
▸ ALDH1A1 P00352 1/20 0.60
▸ THRB P10828 1/20 0.60
▸ CYP2C9 P11712 1/20 0.60
▸ CYP2C19 P33261 1/20 0.60
▸ HSD17B10 Q99714 1/20 0.60
▸ CA12 O43570 1/20 0.58
▸ CA7 P43166 1/20 0.58
▸ CA9 Q16790 1/20 0.58
▸ CA14 Q9ULX7 1/20 0.58
▸ KDM4E B2RXH2 1/20 0.56
▸ ATM Q13315 2/20 0.54
▸ MC4R P32245 1/20 0.54
▸ MC3R P41968 1/20 0.54
▸ TSHR P16473 1/20 0.53
▸ POLB P06746 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139809 0.92 OPRK1 (0.69) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL30581395 0.92 OPRK1 (0.69) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL30581396 0.92 OPRK1 (0.69) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL28231245 0.92 OPRK1 (0.69) OPRK1ALDH1A1THRBCYP2C9CYP2C19
Bromide SCHEMBL11571243 0.91 OPRK1 (0.67) OPRK1ALDH1A1THRBCYP2C9CYP2C19
Hydrochloric Acid SCHEMBL29661828 0.91 OPRK1 (0.67) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL20885112 0.90 OPRK1 (0.66) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL11359300 0.89 TSHR (0.67) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL10394119 0.89 TSHR (0.67) OPRK1ALDH1A1THRBCYP2C9CYP2C19
SCHEMBL11597665 0.89 TSHR (0.67) OPRK1ALDH1A1THRBCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024261749-A1 ANTIMICROBIAL PEPTIDE-METAL COMPLEXES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-12-26 — — WO claimed
US-20240206465-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-06-27 — — US claimed
EP-4326064-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2024-02-28 — — EP claimed
WO-2022224247-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2022-10-27 — — WO claimed
WO-2024261749-A1 ANTIMICROBIAL PEPTIDE-METAL COMPLEXES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-12-26 — — WO disclosed
US-20240206465-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2024-06-27 — — US disclosed
EP-4326064-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) 2024-02-28 — — EP disclosed
WO-2022224247-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2022-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240206465-A1 ACTIVE POLYMERIC FILMS AND POLYMERIC COMPOSITIONS PUF60, PARG, PGLS OPRK1 4359/4885NOS2 1092/4885NOS3 1060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback